Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-24-000042
Filing Date
2024-11-12
Accepted
2024-11-12 16:17:04
Documents
103
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20240930.htm   iXBRL 10-Q 2020702
2 EX-31.1 amrx-2024093010xqexx311.htm EX-31.1 10357
3 EX-31.2 amrx-2024093010xqexx312.htm EX-31.2 10274
4 EX-31.3 amrx-2024093010xqexx313.htm EX-31.3 10431
5 EX-32.1 amrx-2024093010xqexx321.htm EX-32.1 5627
6 EX-32.2 amrx-2024093010xqexx322.htm EX-32.2 5573
7 EX-32.3 amrx-2024093010xqexx323.htm EX-32.3 5661
  Complete submission text file 0001723128-24-000042.txt   10961548

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20240930.xsd EX-101.SCH 87822
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20240930_cal.xml EX-101.CAL 92785
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20240930_def.xml EX-101.DEF 372817
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20240930_lab.xml EX-101.LAB 854569
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20240930_pre.xml EX-101.PRE 600655
106 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20240930_htm.xml XML 1916715
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 241448454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)